Welcome to our dedicated page for USANA Health Sciences news (Ticker: USNA), a resource for investors and traders seeking the latest updates and insights on USANA Health Sciences stock.
USANA Health Sciences Inc (NYSE: USNA) is a U.S.-based company that specializes in developing, manufacturing, and distributing science-backed nutritional and personal-care products. Founded in 1992 by the internationally recognized microbiologist and immunologist, Dr. Myron Wentz, USANA is committed to enhancing the well-being of its customers through high-quality health products. The company operates primarily through a network marketing model, providing rewarding financial opportunities for its independent associates, shareholders, and employees.
USANA's product lines are comprehensive and diverse, catering to various health and nutritional needs. The Essentials line includes core vitamin and mineral supplements. Optimizers offer targeted supplements for specific health requirements. The Foods line features low-glycemic meal replacement shakes and snack bars, promoting balanced nutrition. Sense Beautiful Science offers personal-care products designed for skin and hair health. These products are developed and manufactured in top-notch facilities, ensuring the highest standards of quality and efficacy.
The company's influence extends globally, with operations in Asia-Pacific, the Americas, and Europe. USANA's commitment to innovation is reflected in their proprietary technologies, such as the award-winning InCelligence Technology™ used in their products. Recent achievements include multiple awards at the Korea Medical Healthcare Awards, where USANA's HealthPak and Nutrimeal Active were recognized for their excellence in the multivitamin and weight management categories, respectively.
USANA emphasizes continuous learning and personal growth, as highlighted by their leadership's advocacy for a growth mindset and self-care initiatives. Kevin Guest, the executive chairman of USANA, frequently shares insights that underline the importance of personal development and community contribution. For instance, during Leap Day 2024, Guest proposed seven strategies for making the most of the extra day, ranging from meditation to volunteering.
Moreover, USANA’s financial health and operational integrity have been robust, thanks to their clear communication and strong relationships with customers and distributors across 25 countries. Their dedication to quality and excellence has earned them a solid reputation, making USANA a trusted name in health and wellness. To learn more about their latest products and initiatives, visit their official website at USANA.com.
USANA Health Sciences announced that its Celavive Postbiotic Barrier Balm has been named to BELLA magazine's 2024 Best in Skincare award list. This recognition highlights the product's quality and effectiveness in catering to various skin types and concerns. The Postbiotic Barrier Balm, which features postbiotic Lactobacillus Ferment, cupuacu butter, and five ceramides, has been a top seller since its launch. USANA's executives expressed pride in this achievement, emphasizing the product's role in distinguishing the company in the competitive skincare market.
On May 15, 2024, USANA announced that its vice president of HR, Mike Sessions, was honored with the HR Achievement Award from Utah Business Magazine. This award highlights Sessions' excellence in HR, marking the second consecutive year a USANA HR professional has received this recognition. Under Sessions' leadership, USANA has improved its benefits package, wellness program, and introduced USANACare, an on-site medical and mental health clinic. Sessions has been with USANA for 20 years, starting as an HR assistant in 2004 and becoming VP of HR in August 2021.
USANA Executive Chairman Kevin Guest advocates for family wellness during May's Family Wellness Month, emphasizing the importance of family bonds and health. Guest promotes connection, setting health goals, and regular communication to strengthen family relationships. His message extends from personal experiences to USANA Health Sciences' mission of creating the healthiest family on earth.
USANA Health Sciences, Inc. reported financial results for Q1 2024, with net sales at $228 million, a decrease from Q1 2023. Diluted EPS was $0.86 compared to $0.95 in Q1 2023. The company reiterated its fiscal year 2024 net sales and EPS outlook. Despite strong growth in China, results in other key markets fell short of expectations. The company remains focused on accelerating growth in 2024 through engagement with Associate leaders worldwide. USANA also completed its first quarter of operations in India with expectations of long-term growth.
USANA recently released its fourth annual sustainability report, showcasing its commitment to sustainability and positive business practices. The report highlights achievements such as employee engagement, gender diversity in leadership, renewable energy use, waste diversion, plastic reduction, meals provided through the USANA Foundation, and investment in research and development.
FAQ
What is the current stock price of USANA Health Sciences (USNA)?
What is the market cap of USANA Health Sciences (USNA)?
What is USANA Health Sciences?
When was USANA founded?
What are USANA's main product lines?
How does USANA distribute its products?
What recent awards has USANA won?
What is USANA's InCelligence Technology?
Who is Kevin Guest?
Where does USANA operate?
What is USANA's mission?
How can I learn more about USANA's products?
